Takeda Pharmaceutical Co. Ltd. has announced an agreement with Research Foundation for Microbial Diseases (BIKEN), of Osaka University, to sell the latter's live attenuated varicella (chickenpox) vaccine. The product will be launched in February; no financial details pertaining to the deal were disclosed.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4,288 JPY | -0.49% |
|
-0.63% | +5.70% |
07-17 | Asian Equities Traded in the US as American Depositary Receipts Tumble in Wednesday Trading | MT |
07-17 | Zydus Lifesciences Signs Licensing Pact to Market Vonoprazan in India | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.70% | 42.37B | |
+55.35% | 848B | |
+31.64% | 627B | |
-0.10% | 363B | |
+15.47% | 318B | |
+13.10% | 299B | |
+15.51% | 243B | |
+16.72% | 225B | |
+16.54% | 179B | |
+4.31% | 167B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Takeda Pharmaceutical Co. Ltd to Sell BIKEN's Varicella Vaccine in Japan